Goutham Narla

Affiliations: 
Cancer Biology Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Molecular Biology, Cell Biology, Genetics, Oncology
Google:
"Goutham Narla"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Narla G. (2021) Food and science: Lessons learned from a great chef. American Journal of Hematology
Brautigan DL, Farrington C, Narla G. (2021) Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents. Clinical Science (London, England : 1979). 135: 1545-1556
Laine A, Nagelli SG, Farrington C, et al. (2021) CIP2A interacts with TopBP1 and drives basal-like breast cancer tumorigenesis. Cancer Research
Cox CK, Pandit A, Zawistowski M, et al. (2021) Genome-Wide Association Study of Pelvic Organ Prolapse Using the Michigan Genomics Initiative. Female Pelvic Medicine & Reconstructive Surgery
Kaemmer CA, Umesalma S, Maharjan CK, et al. (2021) Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis. Scientific Reports. 11: 10252
Lee RT, Yang P, Alahmadi A, et al. (2021) Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series. Case Reports in Oncology. 14: 224-231
Scarpa M, Singh P, Bailey CM, et al. (2021) PP2A-activating drugs enhance FLT3 inhibitor efficacy through AKT inhibition-dependent GSK-3β-mediated c-Myc and Pim-1 proteasomal degradation. Molecular Cancer Therapeutics
He X, Li M, Yu H, et al. (2020) Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex. Plos Biology. 18: e3000803
Noto FK, Sangodkar J, Adedeji BT, et al. (2020) The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies. Plos One. 15: e0240169
Merisaari J, Denisova OV, Doroszko M, et al. (2020) Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma. Brain Communications. 2: fcaa002
See more...